Tech Transfer Roundup: Busy Inspyr Collaborates With Virginia, NYU

University researchers will examine adenosine receptor modulator technology’s potential in C. difficile infection and atherosclerosis. CRISPR Therapeutics is partnering with University of Alabama-Birmingham to evaluate gene-editing procedures in Friedreich’s ataxia.

Tech Transfer regular column feature image

Below is Scrip’s monthly roundup, including information from Strategic Transactions, of recent technology transfer agreements between companies and academic or other research institutions.

California biotech Inspyr Therapeutics Inc

More from Deals

More from Business